VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.640
+0.001 (0.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $21.32 million as of April 29, 2026. Its market cap has decreased by -5.27% in one year.
Market Cap
21.32M
Enterprise Value
-7.68M
1-Year Change
-5.27%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $21.32M, a decrease of -90.72%. That is a compound annual growth rate of -32.13%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vistagen Therapeutics | 23.53M |
| Jasper Therapeutics | 23.47M |
| Lexaria Bioscience | 23.39M |
| Marker Therapeutics | 23.34M |
| OSR Holdings | 22.96M |
| Quince Therapeutics | 22.17M |
| Exicure | 22.12M |
| NewcelX | 21.24M |